Retrospective Data Collection on Betaferon Use in Children and Adolescents With MS
Condition:   Multiple Sclerosis Intervention:   Drug: Interferon beta-1b (Betaseron, Betaferon, BAY86-5046) Sponsor:   Bayer Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 4, 2018 Category: Research Source Type: clinical trials

Betaferon Use in Children and Adolescents With Multiple Sclerosis
Condition:   Multiple Sclerosis Intervention:   Drug: Interferon beta-1b (Betaseron, Betaferon, BAY86-5046) Sponsor:   Bayer Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 4, 2018 Category: Research Source Type: clinical trials

Study of Betaferon Adherence in Patients With Multiple Sclerosis Treated With Interferon Beta-1b
Condition:   Multiple Sclerosis Intervention:   Drug: Interferon beta-1b (Betaseron, BAY86-5046) Sponsor:   Bayer Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 23, 2018 Category: Research Source Type: clinical trials

MERS-CoV Infection tReated With A Combination of Lopinavir /Ritonavir and Interferon Beta-1b
Condition :   Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Interventions :   Drug: Combination of Lopinavir /Ritonavir and Interferon beta-1b;   Drug: Placebo Sponsor :   King Abdullah International Medical Research Center Not yet recruiting - verified July 2016 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 20, 2016 Category: Research Source Type: clinical trials

MERS-CoV Infection tReated With A Combination of Lopinavir /Ritonavir and Interferon Beta-1b
Condition:   Middle East Respiratory Syndrome Coronavirus (MERS-CoV)Interventions:   Drug: Combination of Lopinavir /Ritonavir and Interferon beta-1b;   Drug: PlaceboSponsor:   King Abdullah International Medical Research CenterNot yet recruiting - verified July 2016 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 20, 2016 Category: Research Source Type: clinical trials

MERS-CoV Infection tReated With A Combination of Lopinavir /Ritonavir and Interferon Beta-1b
Condition:   Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Interventions:   Drug: Combination of Lopinavir /Ritonavir and Interferon beta-1b;   Drug: Placebo Sponsor:   King Abdullah International Medical Research Center Not yet recruiting - verified July 2016 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 20, 2016 Category: Research Source Type: clinical trials

Hematopoietic Stem Cell Therapy for Inflammatory Multiple Sclerosis Failing Alternate Approved Therapy
Conditions:   Multiple Sclerosis;   Multiple Sclerosis, Relapsing-Remitting Interventions:   Drug: Tecfidera (BG12);   Drug: Gilenya;   Drug: Tysabri®;   Drug: Avonex/Betaseron/Copaxone/Rebif;   Procedure: Hematopoietic stem cell transplantation (HSCT) Sponsor:   Sheffield Teaching Hospitals NHS Foundation Trust Recruiting - verified July 2016 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 21, 2016 Category: Research Source Type: clinical trials